Search Within

Elisa De Stanchina

  1. "Center for Hematologic Malignancies"
Formats
  1. Journal Article (81)
  2. Meeting Abstract (26)
  3. Book Section (2)
Groups
  1. Center for Hematologic Malignancies (109)
  2. GSK Faculty (102)
  3. Sloan Kettering Institute Postdocs (89)
  4. Executive Committee, Center for Hematologic Malignancies (80)
  5. Department of Medicine (78)
  6. Sloan Kettering Institute Faculty (78)

More Groups

People
  1. Scott Lowe (31)
  2. Charles Sawyers (18)
  3. Anas Younes (13)
  4. Omar Abdel-Wahab (13)
  5. Yu-jui Ho (12)
  6. Amanda Kulick (11)

More People

Years
  1. 2025 (8)
  2. 2024 (6)
  3. 2023 (9)
  4. 2022 (13)
  5. 2021 (10)
  6. 2020 (8)

More Years

Publications
  1. Blood (15)
  2. Cancer Research (12)
  3. Cancer Cell (9)
  4. Cancer Discovery (8)
  5. Nature Communications (6)
  6. Proceedings of the National Academy of Sciences of the United States of America (6)

More Publications

Publishers
  1. American Association for Cancer Research (23)
  2. Cell Press (19)
  3. Nature Publishing Group (16)
  4. American Society of Hematology (15)
  5. National Academy of Sciences (6)
  6. American Association for the Advancement of Science (5)

More Publishers

Results (109)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ERG-driven prostate cancer initiation is cell-context dependent and requires KMT2A and DOT1L
    Journal Article

    Feng, W.; Ladewig, E.; Lange, M.; Salsabeel, N.; Zhao, H.; Lee, Y. S.; Gopalan, A.; Luo, H.; Kang, W.; Fan, N.; more...
    Nature Genetics (2025)

    Fulltext@MSK | Save
  • A RAS(ON) multi-selective inhibitor combination therapy triggers long-term tumor control through senescence-associated tumor-immune equilibrium in pancreatic ductal adenocarcinoma
    Journal Article

    Broderick, C.; Mezzadra, R.; Sisso, E. M.; Mbuga, F.; Raghulan, R.; Chaves-Pérez, A.; Kulick, A.; Jiang, L.; Jiang, J.; Ho, Y. J.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer
    Journal Article

    Rousseau, B.; Patel, M.; Artz, O.; Vlachos, G.; Patel, S.; Hayatt, O.; Argilés, G.; Foote, M. B.; Luo, L.; Shah, R.; more...
    Cancer Cell (2025)

    Fulltext@MSK | Save
  • Direct inhibition of RAS reveals the features of oncogenic signaling driven by RAS G12 and Q61 mutations
    Journal Article

    Marasco, M.; Kumar, D.; Garcia Borrego, S.; Seale, T.; Maddalena, G.; Mezzadra, R.; Belanger, K.; Cole, S.; Perez, B.; Luan, W.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
    Journal Article

    Fiore, D.; Cappelli, L. V.; Zhaoqi, L.; Kotlov, N.; Sorokina, M.; Phillip, J.; Zumbo, P.; Yoffe, L.; Ghione, P.; Wang, A.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save
  • RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs
    Journal Article

    Krishnamoorthy, G. P.; Glover, A. R.; Untch, B. R.; Sigcha-Coello, N.; Xu, B.; Vukel, D.; Liu, Y.; Tiedje, V.; Pineda, J. M. B.; Berman, K.; more...
    Journal of Experimental Medicine (2025)

    Fulltext@MSK | Save
  • Metabolic engineering to facilitate anti-tumor immunity
    Journal Article

    Schild, T.; Wallisch, P.; Zhao, Y.; Wang, Y. T.; Haughton, L.; Chirayil, R.; Pierpont, K.; Chen, K.; Nunes-Violante, S.; Cross, J.; more...
    Cancer Cell (2025)

    Fulltext@MSK | Save
  • Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
    Journal Article

    Mao, N.; Lee, Y. S.; Salsabeel, N.; Zhang, Z.; Li, D.; Kaur, H.; Chen, X.; Chang, Q.; Mehta, S.; Barnes, J.; more...
    Science Advances (2025)

    Fulltext@MSK | Save
  • Development of CAR T cells targeting U5 snRNP200 for the treatment of acute myeloid and B-lymphoid leukemias
    Meeting Abstract

    Fujino, T.; Lewis, J.; Chen, B. Y.; Sievers, Q.; Cai, W.; Yoo, S.; Mathew, S.; Souness, S.; Burns, E. R.; Um, J. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
    Journal Article

    Romero, R.; Chu, T.; González Robles, T. J.; Smith, P.; Xie, Y.; Kaur, H.; Yoder, S.; Zhao, H.; Mao, C.; Kang, W.; more...
    Nature Cancer (2024)

    Fulltext@MSK | Save